You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:
To purchase this research report please login here.If you are new to InvestSMART then please click here to become a member - it's FREE!
Current Price Data+
Current Price
Open
High
Low
Last Close
Volume
Price Movement
$ 3.610
$ 3.580
$ 3.610
$ 3.570
$ 3.630
1,026,456
$ -0.020 -0.551 %
Current Broker Consensus Recommendation
Recommendation :
Sell
Recommendation Date :
22nd Jul 2010
12 Month Target Price (average) :
$4.269
Brokers Surveyed :
10
Market Statistics
% of Market:
0.1359
% of Sector:
6.0325
Sector:
Health Care
Industry Group:
Health Care Equipment & Services
Industry:
Health Care Providers & Services
Company Overview
Company Overview
Primary Health Care Limited (PRY) is a service company to medical and allied health professionals offering a range of medical and related services in its network of medial centres and pathology centres across Australia. PRY is also a provider of healthcare technology solutions to medical practitioners, medical practices and hospitals.
Company History
PRY has its origins in the late 1970s when Dr Edmund Bateman established a general practice at Manly. Bateman later formed the company Primary Health and opened a second centre at Chatswood. It listed on the ASX in July 1998. Since listing, PRY has opened numerous additional centres and diversified into pathology and related services. The largest step to-date in the development of PRY happened in March 2008, when the $2.6B acquisition of Symbion was completed.
Differentiating Factor
PRY provides an integrated service to GPs and other health practitioners. It provides a standardised service across its centres, including the integration of the latest IT technology, allowing doctors instant access to pathology, radiology and other test results.
Major Customers & Competitors
PRY's customers are primarily doctors, chemists and other specialists who lease its premises and utilise its services. Some of PRY's operations such as its pathology laboratories also service the public directly. PRY competes with various other healthcare service providers, including Sonic Healthcare and Healthscope in pathology, Sonic (and to a much lesser extent Healthscope) in medical centres and Sonic and DCA Group in radiology.
Financial Summary
Year to Jun
NPAT Rep $M
NPAT1 Adj $M
EPS c
EPS chg %
PER x
PER rel All Ords x
PER rel Sector x
DPS c
Yield %
Franking %
ROE %
2007A
56.9
56.9
31.9
16.0
11.3
n/a
n/a
32.5
9.0
100.0
13.9
2008A
6.8
54.8
19.8
-37.9
18.2
n/a
n/a
27.0
7.5
100.0
3.1
2009A
108.5
106.9
28.2
42.4
12.8
1.2
1.1
14.0
3.9
100.0
5.1
1NPAT is normalised by removing non-recurring items and goodwill. All the above statistics are derived from normalised earnings.
Sydney Morning Herald 31/07/2010 | GRAINCORP and AWB have agreed on a multibillion-dollar merger so they can compete against larger rivals in the consolidating global agribusiness sector.
The Age 31/07/2010 | GRAINCORP and AWB have agreed to a multibillion-dollar merger in a bid to compete against larger rivals in an increasingly consolidating global agribusiness sector.
Sydney Morning Herald 31/07/2010 | I t's official: money doesn't buy you happiness. But financial security certainly seems to play a role in whether you're a glass half full or glass half empty type of person.
The Age 31/07/2010 | This reporting season will provide something for everyone, from wary retail investors and professional fund managers to stockbroking analysts, writes Ian McIlwraith.
Sydney Morning Herald 31/07/2010 | Most of us want to make a buck and retire early. But for the golden oldies of business, there's no question of quitting, writes Michael Evans.
$ 3.610
